Assessment of the observed incidence against expected incidence of CLL MRD demonstrated a highly significant correlation between the CD160-ROR1FCA and ERIC assays throughout the spiking experiments, confirming the proof of concept for both (data not shown). This evidence concerns the gene CD160 and B-cell chronic lymphocytic leukemia.